Evidence map›Paper›PMID 25218479›Full record

ReviewNeuroscience letters2015

Toxic neuropathies: Mechanistic insights based on a chemical perspective.

Richard M LoPachin, Terrence Gavin

Abstract readReview
In one paragraph

Review in Neuroscience letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Pathological classification of equine recurrent laryngeal neuropathy.Journal of veterinary internal medicine · 2018
    Review
  14. Extract ofNeural regeneration research · 2017
    Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Richard M LoPachinDepartment of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, United States. Electronic address: richard.lopachin@einstein.yu.edu.
Terrence GavinDepartment of Chemistry, Iona College, 402 North Avenue, New Rochelle, NY 10804, United States.
Iona College · USMontefiore Medical Center · US

Funding

The Nerve Terminal as the Site of Action for Type-2 AlkenesR01ES003830 · NIEHS · UNIVERSITY OF HOUSTON · PI LOPACHIN, RICHARD MICHAEL · 1986 to 2015
$4.6M
MOLECULAR MECHANISMS OF HEXACARBON-INDUCED AXON ATROPHYR01ES007912 · NIEHS · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI LOPACHIN, RICHARD MICHAEL · 1997 to 2009
$2.4M
NIEHS NIH HHS R01 ES003830NIEHS NIH HHS R01 ES007912NIEHS NIH HHS R01ES03830-26NIEHS NIH HHS R01ES07912-11
6 · The paper itself

Abstract

2,5-Hexanedione (HD) and acrylamide (ACR) are considered to be prototypical among chemical toxicants that cause central-peripheral axonopathies characterized by distal axon swelling and degeneration. Because the demise of distal regions was assumed to be causally related to the onset of neurotoxicity, substantial effort was devoted to deciphering the respective mechanisms. Continued research, however, revealed that expression of the presumed hallmark morphological features was dependent upon the daily rate of toxicant exposure. Indeed, many studies reported that the corresponding axonopathic changes were late developing effects that occurred independent of behavioral and/or functional neurotoxicity. This suggested that the toxic axonopathy classification might be based on epiphenomena related to dose-rate. Therefore, the goal of this mini-review is to discuss how quantitative morphometric analyses and the establishment of dose-dependent relationships helped distinguish primary, mechanistically relevant toxicant effects from non-specific consequences. Perhaps more importantly, we will discuss how knowledge of neurotoxicant chemical nature can guide molecular-level research toward a better, more rational understanding of mechanism. Our discussion will focus on HD, the neurotoxic γ-diketone metabolite of the industrial solvents n-hexane and methyl-n-butyl ketone. Early investigations suggested that HD caused giant neurofilamentous axonal swellings and eventual degeneration in CNS and PNS. However, as our review will point out, this interpretation underwent several iterations as the understanding of γ-diketone chemistry improved and more quantitative experimental approaches were implemented. The chemical concepts and design strategies discussed in this mini-review are broadly applicable to the mechanistic studies of other chemicals (e.g., n-propyl bromine, methyl methacrylate) that cause toxic neuropathies.

Indexed as

AxonsCentral Nervous System DiseasesEnvironmental PollutantsHexanonesHumansPeripheral Nervous System Diseases2,5-hexanedioneEnvironmental PollutantsHexanones2,5-HexanedioneAcrylamideCentral–peripheral distal axonopathyDying back neuropathyNeurotoxicityPeripheral neuropathy

Identifiers

PMID25218479
PMCPMC4362956
OpenAlexW2057054871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.